E146: Did the Fed break the VC model? Plus IPOs, M&A, revaluing unicorns & more

All-In with Chamath, Jason, Sacks & Friedberg Podcast Recap

Published:

What Happened

The episode opens with a discussion on Vivek Ramaswamy's political momentum, as he positions himself as a younger alternative to Donald Trump. Polls in New Hampshire show him gaining traction, potentially surpassing Ron DeSantis, with plans to significantly reduce the federal government's size.

David Sacks raises concerns about candidates who might escalate the Ukraine conflict, emphasizing the necessity of avoiding a global conflict. He advocates for bipartisan efforts to tackle the U.S. fiscal emergency, referencing Ray Dalio's call for a Manhattan Project-style initiative to address the trillion-dollar annual debt service costs.

The hosts analyze the recent IPOs of Instacart, Klaviyo, and Arm, marking a resurgence in venture-backed companies going public after a 21-month hiatus. Instacart's valuation has notably decreased from $39 billion to $8 billion, and the company is seeing 15% year-over-year revenue growth with significant ad revenue contributions.

Klaviyo's IPO is highlighted as a key indicator for SaaS companies in the coming years, with a strong 56% growth rate and a net revenue retention rate of 119%. However, the dependency on Shopify for 70% of its business poses a risk, despite Shopify's strategic investment in Klaviyo.

The episode details the shift in the venture capital landscape due to the Federal Reserve's stance on maintaining higher interest rates. This has led to a scarcity of capital, impacting startup valuations and forcing founders to focus on efficiency and performance rather than relying on large capital raises.

Chamath Palihapitiya and others reflect on the changing dynamics of IPOs in America, where the lack of anchor buyers and lockup periods have led to a 'heads I win, tails you lose' scenario for bankers. The conversation also touches on global economic shifts, with Japan's bond auctions lagging and capital flowing westward for better returns.

The automotive industry faces challenges with union demands for higher wages and a shorter workweek, with potential existential threats if these demands are met. Tesla's price reductions contrast with the issues faced by traditional automakers, highlighting the competitive pressures in the industry.

New scientific advancements in treating autoimmune diseases are discussed, with a novel approach involving glycosylating antigens to prevent immune system attacks. This could provide breakthroughs for conditions such as lupus and rheumatoid arthritis, offering potential alternatives to current treatments that have significant limitations.

Key Insights

View all All-In with Chamath, Jason, Sacks & Friedberg recaps